Optic nerve sheath meningeoma: From expectation to active treatment;Synsnervemeningeomer - Fra avventende holdning til aktiv behandling

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 4, 2005, Pages 429-430

  Kerty, Emilia ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLINDNESS; DETERIORATION; EYE MOVEMENT DISORDER; HUMAN; MENINGIOMA; NERVE SHEATH TUMOR; OPTIC NERVE SHEATH MENINGIOMA; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; TUMOR GROWTH; VISUAL DISORDER; ADULT; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; METHODOLOGY; OPTIC NERVE TUMOR; RADIATION DOSE FRACTIONATION; STEREOTAXIC SURGERY; VISUAL FIELD;

ADULT; DOSE FRACTIONATION; FEMALE; HUMANS; MENINGIOMA; OPTIC NERVE NEOPLASMS; RADIOTHERAPY, CONFORMAL; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME; VISUAL FIELDS;

EID: 14244264564     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sibony PA, Krauss HR, Kennerdell JS et al. Optic nerve sheath meningeomas: clinical manifestations. Ophthalmology 1984; 91: 1313-26.
2. Dutton JJ. Optic nerve sheath meningeomas. Surv Ophthalmol 1992; 37: 167-83.
3. Frisen L, Hoyt WF, Tengroth BM. Optociliary veins, disc pallor, and visual loss: a triad of signs indicating spheno-orbital meningeoma. Acta Ophthamol (Copenh) 1973; 57: 241-9.
4. Bakke SJ, Kerty E. Valg av nevroradiologiske metoder i oftalmologien: synsnerven, øyemusklene og orbita. Tidsskr Nor Lægeforen 2001; 121: 1361-4.
5. Gushing H, Eisenhardt L. Meningeomas: their classification, regional behavior, life history and surgical end results. Springfield: Charles C. Thomas, 1938: 250-82.
6. Mark LE, Kennerdell JS, Maroon JC. Microsurgical removal of a primary intraorbital meningeoma. Am J Ophthalmol 1987; 86: 704-9.
7. Clark WC, Theofilos CS, Fleming JC. Primary optic nerve sheath meningeomas: report of nine cases. J Neurosurg 1989; 70: 37-40.
8. Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningeomas. Arch Ophthalmol 2002; 120; 1505-8.
9. Miller NR. The evolving management of optic nerve sheath meningeomas. Br J Ophthalmol 2002; 86: 1198.
10. Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88: 4-50.
11. Klink DF, Miller NR, Williams J. Preservation of residual vision 2 years after stereotactic radiosurgery for a presumed optic nerve sheath meningeoma. J Neuroophthalmol 1998; 18: 117-20.
12. Kondziolka D, Niranjan A, Lunsford LD et al. Stereotactic radiosurgery for meningeomas. Neurosurg Clin N Am 1999; 10: 317-25.
13. Subramanian PS, Bressler NM, Miller NR. Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningeoma. Ophthalmology 2004; 111: 565-7.
14. Liu JK, Forman S, Hershewe GL et al. Optic nerve sheath meningeomas: visual improvement after stereotactic radiotherapy. Neurosurgery 2002; 50: 950-7.
15. Andrews DW, Faroozan R, Yang BP et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningeomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery 2002; 51: 890-902.
16. Pitz S, Becker G, Schiefer U et al. Stereotactic fractionated irradiation of optic nerve sheath meningeoma: a new treatment alternative. Br J Ophthalmol 2002; 86: 1265-8.
17. Landert M, Baumert BG, Lütolf UM et al. Outcome of optic nerve sheath meningeomas treated by stereotactic radiotherapy. Neuroophthalmology 2003; 27: 207.